XyonEnT โˆž AutoXyon ๐ŸŽ๏ธ Amazon | CryptoXyon ๐Ÿช™ InvestXyon ๐Ÿ’ฐ Walmart | NovaXyon ๐ŸŒŸ XyonPaw ๐Ÿพ Sofia Gray | ZenXyon ๐Ÿง˜โ€โ™‚๏ธ

Amirix stock rises after fourth-quarter earnings beat (NASDAQ:AMLX) – investxyon
Friday, April 19, 2024
Home Stock Analysis Amirix stock rises after fourth-quarter earnings beat (NASDAQ:AMLX)

Amirix stock rises after fourth-quarter earnings beat (NASDAQ:AMLX)

by xyonent
0 comment
Quarterly Report Concept Company Financial Report Business Charts Wooden Cube Represent.jpg

Mohammad Faisal bin Ramli/iStock, Getty Images

Amyryx Pharmaceuticals (NASDAQ:AMLX) ~23% additional Thursday after the neurological-focused drug company beat Wall Street’s revenue expectations in its fourth-quarter 2023 results and updated the schedule for key late-stage programs.

Cambridge, Massachusetts-based Amylyx (AMLX) reported product revenue of $108.4 million.Broken down in America

You may also like

Leave a Comment

About Us

Investxyon

At InvestXyon, we empower individuals with knowledge for informed investing, financial navigation, and secure futures. Our trusted platform covers investments, stocks, personal finance, retirement, and more.

Feature Posts

Newsletter

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!